Varenicline Tablet, Film Coated
Product Images NDC 70710-1613

6 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 70710-1613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (985b4791 E204 4342 9cab 052cccf4a730 01)

Image (985b4791 E204 4342 9cab 052cccf4a730 01)
Chemical structure diagram of varenicline, the active ingredient in the product Varenicline. The image shows molecular components and bonds characteristic of the compound's chemical composition.*
FDA Label Image

Image (985b4791 E204 4342 9cab 052cccf4a730 02)

Image (985b4791 E204 4342 9cab 052cccf4a730 02)
A bar chart comparing percentage outcomes from several clinical studies involving Varenicline in different dosing regimens and placebo controls. The x-axis labels are study identifiers and treatment groups, while the y-axis shows percentage values up to 60%. Error bars indicate variation within each group.*
FDA Label Image

Image (985b4791 E204 4342 9cab 052cccf4a730 03)

Image (985b4791 E204 4342 9cab 052cccf4a730 03)
A bar chart comparing the percentage outcomes across five different studies (Study 2 to Study 5) for Varenicline 0.5 mg BID, Varenicline 1 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and Placebo. Each study's results are presented as vertical bars with error bars indicating variability or confidence intervals.*
FDA Label Image

Image (985b4791 E204 4342 9cab 052cccf4a730 04)

Image (985b4791 E204 4342 9cab 052cccf4a730 04)
A line graph showing the percentage of continuous abstinent subjects over time with nontreatment follow-up in weeks on the x-axis and percentage abstinent on the y-axis. The graph compares two groups: Varenicline 1 mg BID and placebo, indicating trends of higher abstinence rates for the Varenicline group throughout the follow-up period.*
FDA Label Image

0.5 mg (985b4791 E204 4342 9cab 052cccf4a730 05)

0.5 mg (985b4791 E204 4342 9cab 052cccf4a730 05)
Label for Varenicline Tablets 0.5 mg film-coated tablets by Zydus Pharmaceuticals USA Inc. The label includes dosing strength, packaging details of 56 tablets, storage instructions, child-resistant packaging notice, and manufacturer and distributor information.*
FDA Label Image

1 mg (985b4791 E204 4342 9cab 052cccf4a730 06)

1 mg (985b4791 E204 4342 9cab 052cccf4a730 06)
Label for Varenicline Tablets 1 mg film-coated tablets by Zydus Pharmaceuticals USA Inc. The label states each tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline free base. Package contains 56 tablets and is for prescription use only. Storage instructions and pharmacist dispensing notes are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.